广东微量元素科学
廣東微量元素科學
엄동미량원소과학
GUANGDONG TRACE ELEMENTS SCIENCE
2014年
12期
26-31
,共6页
木塔里甫·买合木提%肖东
木塔裏甫·買閤木提%肖東
목탑리보·매합목제%초동
益生菌%谷氨酰胺%肠内营养%胰腺炎
益生菌%穀氨酰胺%腸內營養%胰腺炎
익생균%곡안선알%장내영양%이선염
probiotics%glutamine%enteral nutrition%acute pancreatitis
目的:研究了益生菌联合谷氨酰胺的肠内营养治疗对恢复重症急性胰腺炎( SAP)的肠道屏障功能的作用。方法将74例重症急性胰腺炎患者随机分为3组:常规肠内营养组( EN组),肠内营养+谷氨酰胺组(G1n组),肠内营养+谷氨酰胺+益生菌制剂组(益生菌组)。治疗第1、7、14、21天进行APACHEⅡ评分,并取血测定血清中的谷氨酰胺、内毒素、 CRP、 D-乳酸水平。结果三组病人APACHEⅡ评分、 CRP均逐渐下降,在第7天, Gln组和益生菌组CRP水平下降,并且与EN组对比,差异有统计学意义,而益生菌组和Gln组在第14天的APACHEⅡ评分与EN组差异有统计学意义。三组患者血清Gln浓度在第7天测定均成不同程度下降, Gln组与益生菌组分别与EN组比较,差异无统计学意义。在第14天,三组Gln水平均上升,益生菌组与EN组对比,差异有统计学意义( P<0.05)。在第7天,益生菌组的血清内毒素、 D-乳酸水平低于EN组,差异有统计学意义。在第14天, Gln组和益生菌组的内毒素水平和D-乳酸水平均低于EN组,差异有统计学意义,益生菌组的DAO水平低于EN组,差异有统计学意义(P<0.05)。结论应用益生菌制剂和Gln的肠内营养能更好地维护肠道黏膜屏障的完整,应用前景广阔。但益生菌制剂和Gln免疫制剂间的协同作用需要进一步论证。
目的:研究瞭益生菌聯閤穀氨酰胺的腸內營養治療對恢複重癥急性胰腺炎( SAP)的腸道屏障功能的作用。方法將74例重癥急性胰腺炎患者隨機分為3組:常規腸內營養組( EN組),腸內營養+穀氨酰胺組(G1n組),腸內營養+穀氨酰胺+益生菌製劑組(益生菌組)。治療第1、7、14、21天進行APACHEⅡ評分,併取血測定血清中的穀氨酰胺、內毒素、 CRP、 D-乳痠水平。結果三組病人APACHEⅡ評分、 CRP均逐漸下降,在第7天, Gln組和益生菌組CRP水平下降,併且與EN組對比,差異有統計學意義,而益生菌組和Gln組在第14天的APACHEⅡ評分與EN組差異有統計學意義。三組患者血清Gln濃度在第7天測定均成不同程度下降, Gln組與益生菌組分彆與EN組比較,差異無統計學意義。在第14天,三組Gln水平均上升,益生菌組與EN組對比,差異有統計學意義( P<0.05)。在第7天,益生菌組的血清內毒素、 D-乳痠水平低于EN組,差異有統計學意義。在第14天, Gln組和益生菌組的內毒素水平和D-乳痠水平均低于EN組,差異有統計學意義,益生菌組的DAO水平低于EN組,差異有統計學意義(P<0.05)。結論應用益生菌製劑和Gln的腸內營養能更好地維護腸道黏膜屏障的完整,應用前景廣闊。但益生菌製劑和Gln免疫製劑間的協同作用需要進一步論證。
목적:연구료익생균연합곡안선알적장내영양치료대회복중증급성이선염( SAP)적장도병장공능적작용。방법장74례중증급성이선염환자수궤분위3조:상규장내영양조( EN조),장내영양+곡안선알조(G1n조),장내영양+곡안선알+익생균제제조(익생균조)。치료제1、7、14、21천진행APACHEⅡ평분,병취혈측정혈청중적곡안선알、내독소、 CRP、 D-유산수평。결과삼조병인APACHEⅡ평분、 CRP균축점하강,재제7천, Gln조화익생균조CRP수평하강,병차여EN조대비,차이유통계학의의,이익생균조화Gln조재제14천적APACHEⅡ평분여EN조차이유통계학의의。삼조환자혈청Gln농도재제7천측정균성불동정도하강, Gln조여익생균조분별여EN조비교,차이무통계학의의。재제14천,삼조Gln수평균상승,익생균조여EN조대비,차이유통계학의의( P<0.05)。재제7천,익생균조적혈청내독소、 D-유산수평저우EN조,차이유통계학의의。재제14천, Gln조화익생균조적내독소수평화D-유산수평균저우EN조,차이유통계학의의,익생균조적DAO수평저우EN조,차이유통계학의의(P<0.05)。결론응용익생균제제화Gln적장내영양능경호지유호장도점막병장적완정,응용전경엄활。단익생균제제화Gln면역제제간적협동작용수요진일보론증。
Objective To evaluate the effect of enteral nutrition supplemented probiotics and glutamine on the intestinal mucosal barrier recovery in patients with severe acute pancreatitis.Methods 74 patients with severe acute pancreatitis were randomly divided into 3 groups: enteral nutrition ( EN group ) , enteral nutrition +glutamine ( G1 n group ) , enteral nutrition +glutamine +probiotics ( probiotics group) .APACHEⅡscore was used to evaluate the patients.Blood samples were collected on day 1, 7, 14, 21 after treatment for the concentration of glutamine, plasma endotoxi, plasma diamine oxidase ( DAO) , C-reactive protein ( CRP) .Results 7 day after treatment, the CRP level of Gln group and probiotics group wers decreasd, there were significance statistical difference when compared with the EN group.There was significant difference among the three groups in APACHEⅡscore.the concentration of glutamine were decreased in the three group on the 7th day after treatment.There was no significant difference among the three groups.The levels of Gln in three groups were rise on the 14th day after treatment.There was significant difference between EN group and probiotics group.The level of plasma endotoxi and D-lactic acid of probiotics group were lower than EN group on 7th day after treatment, The difference was statistically significant.The level of plasma endotoxi and D-lactic acid of probiotics group and Gln group were lower than EN group on 14th day after treatment, the difference was statistically significant. Conclusion Application of probiotics and Gln enteral nutrition can better maintain the intestinal barrier integrity and have broad application prospects.But the synergistic effect between probiotics and Glnimmune need for further study.